Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer - Phillips, Roger M.; Loadman, Paul M.; Reddy, Guru (Cancer chemotherapy and pharmacology, 2019)
Keywords: Antineoplastic Agents - administration & dosage; Antineoplastic Agents - pharmacokinetics; Antineoplastic Agents - pharmacology; Aziridines - administration & dosage; Aziridines - pharmacokinetics; Aziridines - pharmacology; Bladder cancer; Blood; Cancer; Cancer Research; Cell Line, Tumor; Chromatography, High Pressure Liquid; Clinical trials; Half-Life; Hematuria; Hematuria - complications; High-performance liquid chromatography; Humans; In Vitro Techniques; Indolequinones - administration & dosage; Indolequinones - pharmacokinetics; Indolequinones - pharmacology; Invasiveness; Medicine; Medicine & Public Health; Oncology; Pharmacology/Toxicology; Research Design; Short Communication; Statistical analysis; Urinary Bladder Neoplasms - drug therapy; Urine; Non-muscle invasive bladder cancer; Apaziquone; Haematuria